Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Cincinnati, Ohio
Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Clinical Trials in Cincinnati, Ohio
1 recruiting
Cincinnati, Ohio
Showing
1–1
of
1
trials
Recruiting
Phase 2
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Recurrent Diffuse Large B-Cell Lymphoma
+12 more
National Cancer Institute (NCI)
120 enrolled
82 locations
NCT06649812
Feedback